drugset / Trial / NCT06775626

Body Composition and Sport Performance Among Young Female Soccer Players Using Subdermic Etonogestrel

NCT06775626 ↗

Phase 0 Suspended 40 enrolled Maíta Poli de Araújo Organon · collab
Non-randomizedParallel-groupOpen-labelSupportive care

Summary

The goal of this clinical trial study is to evaluate the effect of subdermic etonogestrel implant on body composition, sport performance parameters, quantify bleeding patters and quality of life parameters among young female soccer players.

Timeline

Start
2025-04-01
Primary completion
2025-04-01
Completion
2025-12

Outcome

Outcome not reported

Stopped: “The study was suspended due to non-compliance with the partnership agreement between the research team and the company that would supply Implanon. Therefore, it was not possible to continue the study”

Drugs

EvaluationDrugModalityDoseRoute
Subject Etonogestrel Unknown 68 mg Other

Indications